NCT03527108 Nivolumab Plus Ramucirumab in Patients With Recurrent, Advanced, Metastatic NSCLC Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03523572 Trastuzumab Deruxtecan With Nivolumab in Advanced Breast and Urothelial Cancer Status COMPLETED Phase PHASE1
NCT03522246 A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03521908 A Study to Compare the Risk of a Major Bleeding in Participants Who Received Blood Thinning Medications Following a Blood Clot Status COMPLETED Phase N/A
NCT03521830 Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma Status RECRUITING Phase PHASE2
NCT03521570 Intensity-Modulated Radiation Therapy & Nivolumab for Recurrent or Second Primary Head & Neck Squamous Cell Cancer Status COMPLETED Phase PHASE2
NCT03519256 A Study of Nivolumab or Nivolumab Plus Experimental Medication BMS-986205 With or Without Bacillus Calumette-Guerin (BCG) in BCG Unresponsive Bladder Cancer That Has Not Invaded Into the Muscle Wall of the Bladder Status TERMINATED Phase PHASE2
NCT03518320 Safety and Tolerability of TAR-200 and Nivolumab in Subjects With Muscle-Invasive Bladder Cancer Status TERMINATED Phase PHASE1
NCT03515980 An Investigational Study of Experimental Medication BMS-986231 Given in Participants With Different Levels of Liver Function Status COMPLETED Phase PHASE1
NCT03515655 A Study of Patients Hospitalized With Acute Heart Failure With Reduced Ejection Fraction (HFrEF) Status UNKNOWN Phase N/A
NCT03515083 Better Outcomes for Anticoagulation Treatment Through Observation of Atrial Rhythm Status COMPLETED Phase NA
NCT03509896 Study of Chinese Newly Diagnosed Participants With Philadelphia Chromosome-Positive (Ph+) Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Status COMPLETED Phase N/A
NCT03509883 Bioavailability of Apixaban Sprinkle Compared to Apixaban Capsules Status COMPLETED Phase PHASE1
NCT03508271 Effectiveness of Oral Anticoagulants in Elderly Patients With Non-Valvular Atrial Fibrillation and Heart Failure Status COMPLETED Phase N/A
NCT03508258 Study to Describe Risk of Bleeding in Patients Depending on the Different Anticoagulant Therapy They Are on for Atrial Fibrillation (AF) Status WITHDRAWN Phase N/A
NCT03507699 Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1
NCT03505515 Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer Status COMPLETED Phase N/A
NCT03504696 Effectiveness, Safety and Use of Nivolumab Administered During the French Temporary Authorization for Use in Patients With Advanced Melanoma Status COMPLETED Phase N/A
NCT03502746 Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma Status TERMINATED Phase PHASE2
NCT03502330 APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma Status COMPLETED Phase PHASE1